Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
90
SharesWording
Conditional
How definitive the wording is.No category-specific facts could be extracted from this document.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The acquisition is part of a strategic investment program under the medium-term management plan that uses M&A to acquire new technologies, customers and management resources. The company states that it aims to create synergies between the target company's products and management resources and its medical equipment business, strengthen its business platform and achieve further business expansion.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.